Erwei Song
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Sun Yat-Sen Memerial Hospital of Sun Yat-Sen University · Zhongshan 2nd Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Erwei Song as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:14 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07245901 · Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid TumorsSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · not yet recruiting · Solid Tumor · study chair
- Ph1NCT06530082 · A Single Arm Clinical Study of Dendritic Cell Vaccine Loaded With Circular RNA Encoding Cryptic Peptide for Patients With HER2-negative Advanced Breast CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · not yet recruiting · Breast Neoplasms · principal investigator
- Ph3NCT06316531 · A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast CancerSichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · HER2-positive Breast Cancer · principal investigator
- Ph1NCT06121570 · Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · recruiting · Breast Neoplasms · principal investigator
- Ph1NCT06121557 · Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · recruiting · Breast Neoplasms · principal investigator
- Ph3NCT06079983 · JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer SubjectsJiangsu Alphamab Biopharmaceuticals Co., Ltd · recruiting · Breast Cancer · principal investigator
- Ph1/Ph2NCT05981001 · Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · recruiting · Breast Neoplasms · principal investigator
- Ph1/Ph2NCT05981014 · Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · recruiting · Breast Neoplasms · principal investigator
- Ph1/Ph2NCT05812326 · PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · completed · Advanced Breast Cancer, Breast Neoplasm Malignant Female · principal investigator
- Ph1NCT05461768 · A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2-Positive/Negative Breast Cancer and Other Solid TumorsSichuan Baili Pharmaceutical Co., Ltd. · recruiting · Breast Cancer, Locally Advanced or Metastatic Solid Tumor · principal investigator
- Ph1NCT05339685 · A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid TumorsSichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · Breast Cancer · principal investigator
- Ph1NCT05160545 · A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast CancerSichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · Breast Cancer · principal investigator
- Ph1NCT04993040 · A PK Study of Oraxol in Breast Cancer PatientsAthenex, Inc. · completed · Breastcancer · principal investigator
- Ph2NCT04872985 · Pyrotinib Plus Neoadjuvant Chemotherapy in HR+/HER2-, HER4-High Breast CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · active not recruiting · Breast Cancer, Hormone-receptor Positive Breast Cancer · principal investigator
- N/ANCT03724903 · Ductal Lavage Versus Corticosteroids Therapy for Idiopathic Granulomatous MastitisSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · completed · Granulomatous Mastitis · principal investigator
- Ph2NCT03394287 · A Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBCSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · completed · Breast Cancer · principal investigator
- N/ANCT02794688 · Ductal Lavage in Non-lactating Female Women With MastitisSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · completed · Mastitis · study director
- N/ANCT02656589 · microRNA of Human Epidermal Growth Factor Receptor 2 (HER2)Positive Patient Treated With HerceptinSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · unknown · Breast Cancer · study chair
- N/ANCT02376413 · Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer PatientsSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · withdrawn · Local Recurrence of Malignant Tumor of Breast · principal investigator
- Ph3NCT02062489 · Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer PatientsSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · unknown · Breast Cancer · study chair
- N/ANCT01116869 · China CellSearch StudyJohnson & Johnson Medical, China · completed · Metastatic Breast Cancer, Benign Breast Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 10:14 UTC. The ranking covers the 200 most relevant of 16 PubMed records, and a shared surname and initials can bring in a namesake. All 16 on PubMed
- Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial.J Immunother Cancer · 2020154 citationsRCR 5.6
- 96 citationsRCR 5.7
- 70 citationsRCR 4.5
- 50 citationsRCR 5.0
- 47 citationsRCR 1.2
- A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?Breast Cancer Res Treat · 201143 citationsRCR 1.3
- 23 citationsRCR 0.7
- Circumferential Shaving of the Cavity in Breast-Conserving Surgery: A Randomized Controlled Trial.Ann Surg Oncol · 201918 citationsRCR 1.0
- 15 citationsRCR 3.1
- Preclinical study and phase 2 trial of neoadjuvant pyrotinib combined with chemotherapy in luminal/HER2-low breast cancer: PILHLE-001 study.Cell Rep Med · 20249 citationsRCR 1.1